Sign in

You're signed outSign in or to get full access.

AA

ATLANTIC AMERICAN CORP (AAME)·Q3 2025 Earnings Summary

Executive Summary

  • Q3 2025 delivered year-over-year turnaround: total revenue rose 20.7% to $53.76M and diluted EPS improved to $0.02 from ($0.10) on broad premium growth across Property & Casualty (P&C) and Life & Health; sequentially, EPS fell versus Q2 ($0.15) as market-related unrealized equity losses weighed on GAAP results .
  • Non-GAAP operating income swung positive to $1.615M from ($0.712M) YoY; YTD net income reached $4.695M vs a YTD loss of ($4.680M) last year, underscoring improved underwriting performance and scale benefits .
  • Management highlighted nearly 12% YTD premium growth and strong momentum in both segments, citing new business and retention as key drivers; tone confident on sustaining profitable growth and long-term value creation .
  • No formal guidance provided; near-term stock reaction catalysts include underwriting trajectory, combined ratio discipline, and premium growth durability amid rate actions and segment expansions .

What Went Well and What Went Wrong

What Went Well

  • Premium growth across both segments: Life & Health premiums up 6.9% YoY to $29.47M; P&C up 38.8% YoY to $22.50M, driving total net premiums +18.7% YoY to $51.97M .
  • Non-GAAP operating income improved materially to $1.615M (vs. -$0.712M YoY) as core operations strengthened; management emphasized diversified portfolio and disciplined execution: “Operating income also rose sharply, underscoring the strength of our diversified portfolio and disciplined execution” .
  • Book value per share increased to $5.10 from $4.61 at year-end and $4.94 in Q2, reflecting earnings accretion and equity growth .

What Went Wrong

  • Sequential step-down in EPS and revenue: diluted EPS fell to $0.02 from $0.15 and total revenue decreased to $53.76M from $55.29M; unrealized equity losses of ($0.848M) in Q3 vs gains of $2.609M in Q2 impacted GAAP results .
  • Combined ratio modestly worsened sequentially (approx. 93.8% in Q3 vs 92.9% in Q2) as loss and expense trends ticked up with growth; P&C losses increased sequentially to $17.96M vs $16.01M in Q2 .
  • No explicit guidance provided, limiting external visibility into forward revenue, margin, and loss ratio targets; estimates coverage appears limited .

Financial Results

Headline Metrics vs Prior Periods and Estimates

Metric (USD)Q3 2024Q2 2025Q3 2025
Total Revenue ($USD Millions)$44.519 $55.290 $53.760
Insurance Premiums, Net ($USD Millions)$43.782 $50.146 $51.972
Net Income ($USD Millions)($1.998) $3.316 $0.577
Diluted EPS ($USD)($0.10) $0.15 $0.02
Non-GAAP Operating Income ($USD Millions)($0.712) $1.591 $1.615
Unrealized Gains (Losses) on Equity Securities ($USD Millions)($1.746) $2.609 ($0.848)
Revenue Consensus (S&P Global)N/A*N/A*N/A*
EPS Consensus (S&P Global)N/A*N/A*N/A*
Note: Values retrieved from S&P Global.*

Insurance KPI Trends

KPIQ3 2024Q2 2025Q3 2025
Loss Ratio % (Losses Incurred Net / Net Premiums)70.3% 67.1% 68.3%
Combined Ratio % ((Losses + Commissions & Underwriting) / Net Premiums)96.8% 92.9% 93.8%
Net Investment Income ($USD Millions)$2.477 $2.516 $2.633
Interest Expense ($USD Millions)$0.869 $0.773 $0.779

Segment Breakdown (Premiums and Losses)

SegmentQ3 2024 Premiums ($USD Millions)Q2 2025 Premiums ($USD Millions)Q3 2025 Premiums ($USD Millions)Q3 2024 Losses ($USD Millions)Q2 2025 Losses ($USD Millions)Q3 2025 Losses ($USD Millions)
Life & Health$27.568 $29.005 $29.472 $16.776 $17.634 $17.509
Property & Casualty$16.214 $21.141 $22.500 $13.984 $16.013 $17.962
Total$43.782 $50.146 $51.972 $30.760 $33.647 $35.471

Balance Sheet Snapshot

MetricDec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025
Total Cash & Investments ($USD Millions)$265.696 $268.424 $280.282 $289.514
Total Assets ($USD Millions)$393.428 $388.436 $429.339 $430.855
Debt ($USD Millions)$37.761 $37.760 $37.759 $37.759
Shareholders’ Equity ($USD Millions)$99.613 $102.385 $106.168 $109.488
Book Value per Share ($)$4.61 $4.80 $4.94 $5.10

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
RevenueFY/Q4/Q3 2025N/AN/ANo formal guidance provided
Margins (Loss/Combined Ratio)FY/Q4/Q3 2025N/AN/ANo formal guidance provided
OpEx / Interest / Tax RateFY/Q4/Q3 2025N/AN/ANo formal guidance provided
DividendsFY/Q4/Q3 2025N/AN/ANo updates disclosed

Earnings Call Themes & Trends

No Q3 2025 earnings call transcript was available in the document catalog; analysis below reflects management’s press release commentary across quarters .

TopicPrevious Mentions (Q-2 and Q-1)Current Period (Q3 2025)Trend
Segment Premium GrowthQ2: strong earned premium growth in both segments (inland marine, Medicare supplement, group A&H) ; Q1: life & health new business momentum; property & casualty elevated losses with rate actions expected to help Continued growth across auto liability, inland marine, auto physical damage; Medicare supplement and group A&H; premium revenue nearly 12% YTD Positive, broad-based growth momentum
Underwriting & Combined Ratio DisciplineQ2 combined ratio improved vs prior year (derived from loss/expense) ; Q1 life & health favorable loss experience Combined ratio ~93.8% (derived) with slight sequential uptick; YoY improvement persists Improving YoY; mixed sequential
Market/Investment ImpactsQ2: unrealized equity gains aided GAAP earnings (+$2.609M) Q3: unrealized equity losses ($0.848M) pressured GAAP EPS Volatile; non-core but impactful
Internal Controls / RegulatoryQ2 forward-looking noted material weakness remediation efforts Not reiterated in Q3 releaseMonitoring; limited disclosure in Q3

Management Commentary

  • “Premium revenue grew nearly 12% year-to-date, driven by robust momentum across both property & casualty and life & health segments, supported by new business and solid retention. Operating income also rose sharply… we believe we are well-positioned to sustain profitable growth and create long-term value…” — Hilton H. Howell, Jr., Chairman, President & CEO .
  • “Exceptional financial results this quarter… significant increase in net income and continued improvement in operating income… strong earned premium growth… diversified product offerings… well-positioned to deliver sustained, profitable growth” — Hilton H. Howell, Jr. (Q2) .
  • “Strong quarterly results… improved profitability and solid growth in insurance premiums… new business momentum within life and health… property and casualty operations faced elevated losses; rate adjustments expected to begin positively impacting results” — Hilton H. Howell, Jr. (Q1) .
  • Non-GAAP reminder: operating income excludes tax, realized and unrealized investment gains/losses; intended to isolate core operations .

Q&A Highlights

No earnings call transcript available for Q3 2025; Q&A themes and any guidance clarifications were not accessible in the document set [—].

Estimates Context

  • S&P Global consensus estimates for Q3 2025 appear unavailable for EPS and revenue; as a result, no beat/miss assessment versus Street numbers can be made at this time (company is thinly covered) [—].
  • Actual total revenue recorded: $53.760M; diluted EPS: $0.02 .
  • Consensus fields for Q3 2025 in S&P Global returned as unavailable for EPS and revenue; use caution when benchmarking to peers due to limited coverage. Values retrieved from S&P Global.*

Key Takeaways for Investors

  • YTD turnaround is real: $4.695M net income vs prior-year YTD loss, with premium growth across P&C and Life & Health driving improved core profitability .
  • Sequential volatility tied to markets: unrealized equity losses reduced GAAP EPS in Q3; core operating trend remains positive as seen in non-GAAP operating income .
  • Underwriting discipline: Combined ratio improved YoY; monitor sequential loss trends—especially in auto liability and physical damage—as growth continues .
  • Capital strength: shareholders’ equity rose to $109.5M; book value per share at $5.10, supported by earnings and investment growth .
  • Visibility: absence of formal guidance and limited Street coverage suggests trading may react more to reported combined ratio and premium growth data than to consensus beats/misses .
  • Near-term focus: watch Q4 seasonality, reinsurance costs, and rate actions’ impact on P&C loss trends; Life & Health momentum in Medicare supplement and group A&H appears durable .
  • Medium-term thesis: diversified segment growth, improving core operations, and capital base expansion position AAME to sustain profitable growth; execution on underwriting and rate adequacy remains the key driver .